000 01609 a2200421 4500
005 20250513223240.0
264 0 _c20001208
008 200012s 0 0 eng d
022 _a0020-7136
024 7 _a10.1002/1097-0215(20001115)88:4<652::aid-ijc21>3.0.co;2-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPlonowski, A
245 0 0 _aIn vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215.
_h[electronic resource]
260 _bInternational journal of cancer
_cNov 2000
300 _a652-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntibiotics, Antineoplastic
_xpharmacokinetics
650 0 4 _aBombesin
_xanalogs & derivatives
650 0 4 _aCarboxylic Ester Hydrolases
_xantagonists & inhibitors
650 0 4 _aDoxorubicin
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aPyrroles
_xtherapeutic use
650 0 4 _aReceptors, Bombesin
_xanalysis
650 0 4 _aTumor Cells, Cultured
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aNagy, A
700 1 _aSchally, A V
700 1 _aSun, B
700 1 _aGroot, K
700 1 _aHalmos, G
773 0 _tInternational journal of cancer
_gvol. 88
_gno. 4
_gp. 652-7
856 4 0 _uhttps://doi.org/10.1002/1097-0215(20001115)88:4<652::aid-ijc21>3.0.co;2-1
_zAvailable from publisher's website
999 _c11001421
_d11001421